Compound Detail
CHEMBL35482
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL35482 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QFWCYNPOPKQOKV-UHFFFAOYSA-N |
14
Targets
21
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
267.3
MW (Da)
3.05
ALogP
4
HBA
1
HBD
65.5
PSA (Ų)
0.72
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 21 meas. best 6.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Prostaglandin G/H synthase 1 CHEMBL221 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Histone deacetylase 6 CHEMBL1865 | IC50 | 5.74 | 5.74 | 1837.0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 CHEMBL3587 | IC50 | 5.73 | 5.61 | 1880.0 | 3 |
| Unchecked CHEMBL612545 | IC50 | 5.7 | 5.7 | 2000.0 | 2 |
| Serine/threonine-protein kinase RAF and Dual specificity mitogen-activated protein kinase kinase 1 (Raf/MEK) CHEMBL2111351 | IC50 | 5.55 | 5.55 | 2800.0 | 1 |
| Mitogen-activated protein kinase 1 CHEMBL4040 | IC50 | 5.55 | 5.55 | 2800.0 | 1 |
| Mitogen-activated protein kinase; ERK1/ERK2 CHEMBL1907606 | IC50 | 5.53 | 5.53 | 2950.0 | 1 |
| HT-29 CHEMBL384 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase MEK1/2 CHEMBL3430876 | IC50 | 5.38 | 5.38 | 4200.0 | 1 |
| Luciferin 4-monooxygenase CHEMBL5567 | IC50 | 5.21 | 4.895 | 6200.0 | 4 |
| HT-1080 CHEMBL614580 | IC50 | 5.07 | 5.07 | 8600.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.0 | 4.95 | 10000.0 | 2 |
| WiDr CHEMBL614647 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 2 CHEMBL2964 | IC50 | 4.3 | 4.3 | 50000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20189399 | 10.1016/j.bmc.2010.01.046 | Unchecked | 12 |
| 10998351 | 10.1042/0264-6021:3510095 | Unchecked | 5 |
| 18363348 | 10.1021/jm701302v | Luciferin 4-monooxygenase | 5 |
| 23398362 | 10.1042/bj20121418 | Serine/threonine-protein kinase mTOR | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase HCK | 4 |
| 23398362 | 10.1042/bj20121418 | Cyclin-dependent kinase 5/CDK5 activator 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Protein kinase C beta type | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin-like growth factor 1 receptor | 4 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 4 |
| 23398362 | 10.1042/bj20121418 | cGMP-dependent protein kinase 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin receptor | 4 |
| 21345685 | 10.1016/j.bmc.2011.01.059 | Nuclear factor erythroid 2-related factor 2 | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase Lck | 4 |
| 23791078 | 10.1016/j.bmcl.2013.05.058 | RAW264.7 | 3 |
| 23398362 | 10.1042/bj20121418 | Ephrin type-A receptor 4 | 2 |
| 18363348 | 10.1021/jm701302v | Unchecked | 2 |
| 23398362 | 10.1042/bj20121418 | Death-associated protein kinase 1 | 2 |
| 23398362 | 10.1042/bj20121418 | Ephrin type-A receptor 5 | 2 |
| 23398362 | 10.1042/bj20121418 | Fibroblast growth factor receptor 3 | 2 |
Data from ChEMBL 36 via Core Engine